Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00875355Phase 2Unknown
A Phase 2 trial of temozolomide in breast cancer, sponsored by Institut Curie. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00875355.